XNAS · ADVB
-3.10% · -$0.1650 · Vol 15.3K
Market closed · last close 4:00 PM ET · price as of 15:50:06 ET
Advanced Biomed Inc. Common Stock

Advanced Biomed Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$5.16
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is ADVB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for ADVB are being assembled.
About Advanced Biomed Inc. Common Stock
SERVICES-MEDICAL LABORATORIES
Listed since
2025
Employees
31
Country
US

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.54
Day high
$5.91
Day low
$5.09
Previous close
$5.33
52W high
$5.91
-12.62% from high
52W low
$5.09
8% of range
Market cap
$8.8M
P/E
1.91×
EPS
$-0.1600
Shares out
1.7M
Volume
15.3K
VWAP
$5.38
Price history computed in-house
SMA 50 $5.16 · above
SMA 200 $5.16 · above
52W position 8%
Veridion warehouse edge

Warehouse intelligence for ADVB.

Veridion Score
58
0: 941: 392: 353: Not reported4: Not reported5: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ADVB insider activity

Advanced Biomed Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ADVB.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ADVB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ADVB in this window.
Lobbying spend

ADVB lobbying filings, year to date.

Registered lobbying filings matched to Advanced Biomed Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ADVB in this window.
Latest news · ADVB
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ADVB.
Options
Sovereign unlock shows live options positioning for ADVB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.